Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Meeting Seeks to Boost Interest in the Human Proteome Project

By LabMedica International staff writers
Posted on 13 Sep 2011
Participants in the Human Proteome Project (HPP), a global collaboration among proteomics researchers to map the entire human proteome over the next 5 to 10 years, met in Geneva, Switzerland, at the beginning of September 2011.

The HPP meeting was held as part of a workshop sponsored by AB SCIEX (Framingham, MA, USA), a global leader in life science analytical technologies, and a member of the HPP’s Industry Advisory Board.

HPP is a Human Proteome Organization (Montreal, Canada) initiative that aims to assign and characterize all proteins in the human body. More...
To accomplish this feat the research will proceed in two main directions: chromosome-based HPP (cHPP), focusing on annotating subsets of proteins for each chromosome, and biology disease-driven HPP (bdHPP), aiming to answer biological and disease-related questions.

The practical work of identifying, quantifying, and annotating all human protein-coding genes, the will be accomplished with three primary tools: mass spectrometry, antibody affinity, and bioinformatics. For each of these methods the HPP will be publishing guidelines with recommendations for experimental procedures, sample handling, and data analysis.

The major challenges for the HPP at this time are the need to convince enough large research laboratories to join the consortium, and to ensure sufficient quantitation in order to develop large-scale databases. The ultimate goal is to produce high-quality results that will be universally available to researchers all over the world. In the long term, the HPP aims to take proteomics beyond research and into clinical applications.

Related Links:

AB SCIEX
Human Proteome Organization



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.